The incidence of undiagnosed diabetes accounts for 36% of all diabetes cases among European adults, while 541M adults worldwide live with levels of glucose “higher than normal but not higher enough” to be considered in the range of Type-2 Diabetes – also called “prediabetes” – which constitutes an important risk factor for further diabetes development. Prediabetes itself is not an extensively studied condition compared to the overt diabetes, but – most importantly – it is a condition that can be reversed starting with lifestyle intervention such as diet and physical activity, without medications to not proceed into diabetes.
The aim of the PRAESIIDIUM project is to develop a prototype tool for the real-time prediction of the prediabetic risk based on a series of patient-specific mathematical models (firstly developed during a previous European-funded project) that simulate metabolism, pancreas hormone production, microbiome metabolites, inflammatory process, and immune system response. The prediction algorithm will be based on a “physics-informed machine learning”. Datasets of real-life data will be combined with mathematical models to overcome the limits of a “black-box” machine-learning approach, while reducing the computational time for simulating the solutions of heavy mathematical models and improving its prediction performances.
The consortium will collect the necessary training data from already existing clinical studies and databases which are representative of the real-life scenarios of a prediabetes/diabetes risk insurgence in adulthood: family history, Metabolic Syndrome, Liver disease and morbid obesity. Two new pilot prospective observational studies are also being conducted, during which we will also equip participants with wearable sensors (e.g. glucose monitoring, bioimpedance, heart rate, accelerometer) to obtain real-life and real-time data.
The PRAESIIDIUM consortium – composed of multi-disciplinary experts from universities, research centres, SMEs and large enterprises across five EU nations and the Swiss associated country – is committed to state-of-the-legislation principles for which concerns the fair enrolment of participants in the clinical studies through informed consent, protecting sensitive data and ensuring the transparency, reproducibility and explainability of the machine learning algorithms developed during the project lifespan.
At the end of the project, the algorithm will be implemented in a web-based application where doctors can insert, manage, and monitor data inputs from all the patients, who will be equipped with a mobile app able to collect data also from wearable sensors. While there are some already-available commercial solutions (e.g., web and/or mobile apps) for monitoring diet and physical exercises directed towards metabolic syndrome and/or diabetic people, as well as few commercially available wearable sensors for glucose monitoring, none of these applications are based on real-life data-trained prediction algorithm.
Improvement in prediabetes risk prediction and its progression represents the main goal of the project, therefore the significance of the project is summarised by the consequent reduction of mortality and complications, improvement of patient’s health status and quality of life, reduction of costs supported by individuals, health systems and businesses and an improvement of prediabetes risk management in time of crisis. At the same time, the project will create positive impacts on research community, governments, medical units or associations, and society as a whole.
In the fight against diabetes using artificial intelligence, we are not alone!
Together with the dAIbetes project (https://daibetes.eu/) an innovative, Horizon Europe-funded initiative designed to revolutionize treatment approaches for type 2 diabetes by harnessing the latest advances in artificial intelligence (AI), virtual twin technology and federated learning, we will host a workshop in December 2024, in Rome, Italy. The event will bring together experts together experts from different fields to join our shared mission of improving personalised diabetes prevention and care. Along with the opportunity for knowledge exchange, the workshop is a unique outreach opportunity for young students.
We are looking forward to both planned and future events helping us bringing efforts to #preventDiabetesWithAI